Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antivirals/HIV”

346 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 346 results

Early research (Phase 1)Study completedNCT00000810
What this trial is testing

Randomized, Phase I/II, Dose-Ranging, Open-Label Trial of the Anti-HIV Activity of Delavirdine Mesylate (DLV; U-90,152S)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 120
Testing effectiveness (Phase 2)UnknownNCT01529073
What this trial is testing

Efficacy of Pegylated Interferon Plus Ribavirin Plus Nitazoxanide in HCV Genotype 4 and HIV Coinfection

Who this might be right for
HCV CoinfectionHIV Infection
Juan Macías 45
Not applicableStudy completedNCT00000665
What this trial is testing

Studies of the Ocular Complications of AIDS (SOCA) CMV Retinitis Trial: Foscarnet-Ganciclovir Component

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 240
Early research (Phase 1)Study completedNCT03875209
What this trial is testing

10E8.4/iMab Bispecific Antibody in HIV-uninfected and HIV-infected Adults

Who this might be right for
HIV-1-infection
David Ho 54
Early research (Phase 1)Study completedNCT00090077
What this trial is testing

Monotherapy Versus Placebo Over 7 Days-Non-Nucleoside Reverse Transcriptase Inhibitor-Experienced HIV1 Infected Adults

Who this might be right for
HIV Infections
GlaxoSmithKline 50
Not applicableUnknownNCT02102451
What this trial is testing

Control and Elimination Within Australia of Hepatitis C From People Living With HIV

Who this might be right for
Hepatitis CHIVHIV-HCV Coinfection
Kirby Institute 492
Not applicableUnknownNCT03551002
What this trial is testing

Impact of DAA Uptake in Controlling HCV Epidemic and Modeling Interventions for HCV Elimination Among HIV-infected Persons in San Diego

Who this might be right for
Hepatitis CHepatitis C, ChronicHIV/AIDS
University of California, San Diego 450
Testing effectiveness (Phase 2)Ended earlyNCT00294372
What this trial is testing

Phase II Study on the Antiviral Activity and Safety of BILR 355 BS in HIV-1 Infected, NNRTI-treated Patients

Who this might be right for
HIV Infections
Boehringer Ingelheim 36
Post-approval studies (Phase 4)Study completedNCT03250910
What this trial is testing

Generic VEL/SOF With or Without RBV for HIV/HCV Coinfected Patients

Who this might be right for
Hepatitis C Virus Infection, Response to Therapy ofHuman Immunodeficiency Virus
National Taiwan University Hospital 228
Large-scale testing (Phase 3)Study completedNCT04021290
What this trial is testing

Regimen Switch to Dolutegravir/Lamivudine Fixed Dose Combination From Current Antiretroviral Regimen in HIV-1 Infected and Virologically Suppressed Adults (SALSA)

Who this might be right for
HIV Infections
ViiV Healthcare 493
Early research (Phase 1)Study completedNCT01950325
What this trial is testing

VRC 601: A Phase I, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC HIVMAB060-00-AB (VRC01), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to HIV-Infected...

Who this might be right for
HIV-1 InfectionNeutralizing AntibodyMonoclonal Antibody+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 27
Large-scale testing (Phase 3)Study completedNCT00002389
What this trial is testing

The Safety and Effectiveness of Lamivudine Plus Zidovudine, Used With and Without 1592U89, in HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
Glaxo Wellcome 210
Early research (Phase 1)Study completedNCT03205917
What this trial is testing

A Clinical Trial of PGDM1400 and PGT121 and VRC07-523LS Monoclonal Antibodies in HIV-infected and HIV-uninfected Adults

Who this might be right for
HIV Infections
International AIDS Vaccine Initiative 29
Not applicableStudy completedNCT00002130
What this trial is testing

A Long-Term, Follow-On Safety Study of Four Doses of OPC-8212 (Vesnarinone) in HIV-Infected Persons

Who this might be right for
HIV Infections
Otsuka America Pharmaceutical
Testing effectiveness (Phase 2)Study completedNCT04042740
What this trial is testing

Glecaprevir/Pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus Infection

Who this might be right for
Hepatitis C InfectionHIV Infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 45
Early research (Phase 1)Study completedNCT00110578
What this trial is testing

Safety and Effectiveness of Immunotherapy With Autologous HIV-Specific CD8 Cells in HIV Infected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Early research (Phase 1)UnknownNCT04620291
What this trial is testing

Study for Evaluation of the Safety, Pharmacokinetics, and Antiviral Activity of UB-421 Subcutaneous Formulation in HIV Infected Adults

Who this might be right for
HIV-1-infection
United BioPharma 18
Not applicableUnknownNCT04768517
What this trial is testing

HCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR by Antiviral Therapy

Who this might be right for
Hepatitis C Virus InfectionHepatitis C Virus Infection, Response to Therapy ofHuman Immunodeficiency Virus (HIV) Coinfection
National Taiwan University Hospital 300
Large-scale testing (Phase 3)Study completedNCT00561925
What this trial is testing

VERxVE Study on Efficacy and Safety of Nevirapine XR in Comparison to Nevirapine IR With Truvada in Naive HIV+ Patients

Who this might be right for
HIV Infections
Boehringer Ingelheim 1,068
Early research (Phase 1)Study completedNCT00703586
What this trial is testing

Study of the Antiviral and Immunological Effects of Intensification of Suppressive Antiretroviral Therapy With Maraviroc

Who this might be right for
HIV Infections
Rockefeller University 8
Next Page